Uterine prolapse is remarkably common. When doctors physically examine women for pelvic organ prolapse, roughly 40% show some degree of it. When women are asked about symptoms through questionnaires, the number drops to about 25%, largely because many mild cases cause no noticeable symptoms at all. Either way, this is one of the most prevalent pelvic floor conditions in women, and it becomes more common with age, childbirth, and menopause.
How Prevalence Depends on How You Measure It
The gap between exam-based and symptom-based numbers is significant and worth understanding. A 2024 meta-analysis in the Iranian Journal of Public Health pooled data from studies worldwide and found that physical exams detected pelvic organ prolapse in about 41.8% of women, while questionnaire-based studies found a prevalence of about 25%. Some individual studies showed even wider gaps, with exam-based prevalence reaching as high as 75% to 76%.
Why the difference? Many women with mild prolapse have no symptoms. The pelvic organs may have shifted slightly from their normal position, enough to be measurable on an exam, but not enough to cause a feeling of heaviness, pressure, or bulging. Stigma and lack of awareness also play a role. Women may not report symptoms they feel embarrassed about or don’t recognize as prolapse.
What the Stages Look Like
Doctors grade prolapse on a scale from stage 0 (no descent) to stage IV (the uterus has descended fully outside the body). In a population-based study of middle-aged women, the distribution was heavily weighted toward milder stages: about 9% had stage 0, 21% had stage I, 68% had stage II, and only 2% had stage III. No women in the sample had stage IV. This means the vast majority of prolapse detected on exam is mild to moderate, and the severe cases that most people picture when they hear “prolapsed uterus” are relatively rare.
Vaginal Birth Is the Biggest Risk Factor
A single vaginal delivery increases the odds of prolapse nearly tenfold compared to women who have never given birth. That’s one of the strongest risk factors identified in the research. Interestingly, additional vaginal births after the first don’t significantly increase the risk further. Each subsequent delivery raises the odds by only about 9%, a statistically insignificant bump.
Cesarean delivery tells a different story. Women who delivered exclusively by cesarean have prolapse rates similar to women who never gave birth at all. In one study, the odds ratio for cesarean delivery was just 1.31, meaning essentially no meaningful increase in risk. By age 64, the estimated probability of symptomatic prolapse was 13.4% after vaginal delivery compared to just 1.1% after cesarean delivery. That’s a 12-fold difference.
Among women who delivered vaginally, the prevalence of symptomatic prolapse accelerates with age, rising roughly fourfold from about 3.8% at age 40 to 13.4% at age 64. For women who had cesarean births or no births, the rate stays below 5% through that same age range.
How Menopause and Body Weight Affect Risk
Up to 50% of postmenopausal women have some degree of pelvic organ prolapse. The decline in estrogen after menopause weakens the connective tissues and muscles that hold the pelvic organs in place. Vaginal tissue thins and loses elasticity, and the structural support system gradually deteriorates. This is why prolapse incidence rises steadily with age, even in women who had no symptoms during their reproductive years.
Body weight is another major factor. A large study following women over an average of five years found that being overweight (BMI of 25 to 29.9) increased the risk of uterine prolapse progressing by 43% compared to women at a healthy weight. For women with a BMI of 30 or higher, the risk of progression jumped by 69%. The extra abdominal weight puts chronic downward pressure on the pelvic floor, accelerating the descent of the uterus over time.
Racial and Ethnic Differences
Prolapse does not affect all racial groups equally, at least not in terms of symptoms. In a diverse population-based study, white and Latina women had four to five times the risk of symptomatic prolapse compared to African American women. The prevalence of symptomatic prolapse ranged from about 1% in African American women to 5% in Latina women. When researchers looked at the actual physical exam findings, the degree of prolapse by stage was nearly identical across all racial groups, with stage II accounting for 64% to 69% in every group. White women did have a 40% higher risk of the prolapse reaching or passing the opening of the vagina compared to African American women, but the overall stage distribution was strikingly similar.
This suggests that the structural changes happen at similar rates across races, but the experience of symptoms differs. Whether this reflects differences in tissue composition, pain perception, or other biological factors isn’t fully understood.
Lifetime Risk of Needing Surgery
Not everyone with prolapse needs treatment, and not everyone who needs treatment needs surgery. But for those who do, the numbers are substantial. The estimated lifetime risk that a woman will undergo surgery specifically for pelvic organ prolapse is about 12.6%. By age 80, roughly 126 out of every 1,000 women will have had prolapse surgery. When you combine prolapse surgery with surgery for stress urinary incontinence (a closely related condition), the cumulative risk by age 80 reaches about 200 per 1,000 women, or one in five.
These surgical numbers reflect cases severe enough to warrant intervention. The much larger group of women with mild or moderate prolapse typically manage with pelvic floor exercises, pessaries (supportive devices inserted into the vagina), or simply monitoring over time.